午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Zunsemetinib
Zunsemetinib
  • Zunsemetinib

Zunsemetinib NEW

Price $283 $689 $1180
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-12

Product Details

Product Name: Zunsemetinib CAS No.: 1640282-42-3
Purity: 99.77% Supply Ability: 10g
Release date: 2024/11/12

Product Introduction

Bioactivity

名稱Zunsemetinib
描述Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
體外活性Zunsemetinib selectively blocks p38α MAPK activation of the proinflammatory kinase MK2 while sparing p38α activation of other effectors such as PRAK and ATF2, and inhibits in vitro osteoclast formation induced by RANKL.[1] Zunsemetinib (1 and 10 μM; 1h) decreases IL-1β expression by promoting IL-1β mRNA degradation and has no effect on NLRP3 expression.[1] Zunsemetinib (0.4 nM~1 μM; 16h; PBMC cells) reduces IL-1β secretion and promotes IL-1β mRNA instability.[1]
體內活性Zunsemetinib (1,000 ppm; p.o.; 8-week-old WT female mice) blocks LPS-induced TNF-α expression persisted for up to 4 weeks after dosing.[1] Zunsemetinib (10 and 20 mg/kg; p.o.) prevents osteopenia in NOM IDc mice through inhibition of osteoclastogenesis and increases bone density.[1]
存儲條件store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 80 mg/mL (155.67 mM), Sonication is recommended.
關鍵字ATI 450 | CDD 450 | Zunsemetinib | CDD450 | ATI450
相關產品Sodium lauryl sulfoacetate | Nomilin | Vemurafenib | CMPD1 | SKLB-163 | MBM-55S | sodium lauroyl-α-hydroxyethyl sulfonate | Takinib | NG25 | Selonsertib
相關庫經典已知活性庫 | 已知活性化合物庫

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$/
Anhui Ruihan Technology Co., Ltd
2023-08-21
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY